BLUEPRINT archive item
Epigenomics of Common Diseases
Abstract and Bursary deadline:The 4th Wellcome Trust Epigenomics of Common Diseases conference will bring together leading scientists from the fields of epigenomics, genetics and bioinformatics to discuss the latest developments in this fast-moving field.
28-31 October 2014
Churchill College, Cambridge, UK
9 September|Registration deadline: 30 September
The 4th Wellcome Trust Epigenomics of Common Diseases conference will bring together leading scientists from the fields of epigenomics, genetics and bioinformatics to discuss the latest developments in this fast-moving field.
This meeting will focus on epigenomic studies across a wide range of common and other diseases. It will explore the validation and replication of epigenome-wide association studies, and discuss the latest functional studies and model systems to understand epigenomic regulation. The 2014 programme will also include a debate on transgenerational epigenetic inheritance.
We welcome abstracts from all areas relevant to epigenetic and epigenomic research. Several oral presentations will be chosen from the abstracts submitted.
Topics will include:
Topics will include:
Epigenomics of disease
Model systems: animal and cellular models
Epigenetic gene regulation
Epigenetic epidemiology
Transgenerational epigenomics
Integration of genomics and epigenomics
Informatics and technology
Environmental epigenomics
Single cell epigenomics
Scientific programme committee
Stephan Beck University College London, UK
Susan Clark The Garvan Institute of Medical Research, Australia
Andy Feinberg Johns Hopkins University School of Medicine, USA
Caroline Relton University of Bristol, UK
Keynote speakers
Manolis Kellis, MIT, USA
Tony Kouzarides, Gurdon Institute, UK
Invited speakers
Andrea Baccarelli, Harvard School of Public Health, USA Jordana Bell, King's College London, UK George Davey-Smith, University of Bristol, UK Brian Dias, Emory University, USA Andy Feinberg, Johns Hopkins University School of Medicine, USA Anne Ferguson-Smith, University of Cambridge, UK Eugene Andres Houseman, Oregon State University, USA Steve Horvath, University of California, Los Angeles, USA Andrew Jaffe, Lieber Institute for Brain Development, USA Xiaole Shirley Liu, Dana Farber Cancer Institute/Harvard University, USA Rob Martienssen, Cold Spring Harbor, USA Mark McCarthy, University of Oxford, UK Alexander Meissner, Harvard University, USA Tim Mercer, The Garvan Institute of Medical Research, Australia Wolf Reik, Babraham Institute, UK Caroline Relton, University of Bristol, UK Paolo Sassone-Corsi, University of California, USA Henk Stunnenberg, Radboud University, The Netherlands Benjamin Tycko, Columbia University, USA Emma Whitelaw, QIMR Berghofer Medical Research Institute, Australia
For further information, visit:
https://registration.hinxton.wellcome.ac.uk/display_info.asp?id=441
Related source links
- Home
- Research
- Results
- Participants
- News
- Links
- Contact
- Home
- Contact
- RSS
- Nature Methods paper by Christoph Bock's lab at CeMM
- Paper on ethical issues related to epigenome data release
- Fourth Annual BLUEPRINT Consortium Meeting
- BLUEPRINT Newsletters
- Nature Genetics paper for IDIBAPS team and several other BLUEPRINT teams
- New Frontiers in Epigenetics
- Symposium on 'Network Models in Cellular Regulation'
- IHEC Data Portal
- Cell Reports publication for Christoph Bock and colleagues
- Secondary analysis of Sixth data release
- 4th Annual 450k Methylation Array Analysis Workshop
- Sixth data release
- Two BLUEPRINT papers mentioned as notable advances in 2014
- EPIGENomics and Health Care Policy: Challenges and Opportunities
- 3 publications in Science
- Secondary analysis of Fifth data release
- Third Annual BLUEPRINT Consortium Meeting
- IHEC meeting 2014 - Vancouver
- Fifth data release
- IHEC data portal online
- Epigenomics of Common Diseases
- BLUEPRINT Data Training Session
- Fourth data release
- 3rd Annual Infinium Human Methylation 450 Array Analysis Workshop
- Modelling Approaches in Epigenetics 2014 - An EpiGeneSys and BLUEPRINT joint workshop